OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
Generic: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE is FDA application ANDA207804, sponsored by PRINSTON. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
cGMP Deviations; Olmesartan Medoximil Tablets 20 mg was released in error with alternate API source
Presence of Foreign Tablet/Capsule
Discoloration: This product is being recalled due to a confirmed pharmacist report that tablets from
Failed Dissolution Specifications.
Failed Dissolution Specifications: low dissolution results
cGMP deviations
Failed Dissolution Specifications: Olmesartan Medoxomil content below specifications
Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Out of specification due to dissolution.